Brief: Hedgepath Pharmaceuticals Provides Corporate Update For The Fourth Quarter And Year End 2018
HedgePath Pharmaceuticals Inc HPPI.PK :
* HEDGEPATH PHARMACEUTICALS PROVIDES CORPORATE UPDATE FOR
THE
FOURTH QUARTER AND YEAR END 2018
Source text for Eikon: ID:nPn1MSRVva
Further company coverage: HPPI.PK
Recent news on Inhibitor Therapeutics
See all newsBrief: Inhibitor Therapeutics Receives Prostate Cancer IND Clearance From FDA
Brief: Hedgepath Pharmaceuticals Provides Corporate Update For The Fourth Quarter And Year End 2018
Brief: Hedgepath Pharmaceuticals, Mayne Pharma Enter Updated Collaboration & Funding Agreements
Brief: HedgePath says FDA grants orphan drug designation to its pill